ArticleJournal of the American Heart Association2024

Use of Sodium-Glucose Cotransporter-2 Inhibitors and Angiotensin Receptor-Neprilysin Inhibitors in Patients With Atrial Fibrillation and Heart Failure From 2021 to 2022: An Analysis of Real-World Data.

Alvaro Alonso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.